| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
Market Maker
|
Awaited |
113,000
|
— | ₹1.39 |
|
QIB
|
Over 1.00x
|
— | — | — |
|
NII / HNI
|
Over 1.00x
|
— | — | — |
|
Retail
|
Over 1.00x
|
— | — | — |
| Total | 1.00x | 2,241,000 |
100% | ₹27.56 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| Market Maker | 113,000 | ₹1.39 |
5.04%
|
| Total | 2,241,000 | ₹27.56 |
100.00%
|
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 2,000 | ₹246,000 |
| Retail (Max — 13 Lots) | 13 | 13,000 | ₹1,599,000 |
| S-HNI (Min — 14 Lots) | 14 | 14,000 | ₹1,722,000 |
| B-HNI (Min — 68 Lots) | 68 | 68,000 | ₹8,364,000 |
| Particulars | 31 May 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue from Operations | 6.21 | 25.61 | 15.84 |
| EBITDA | 1.93 | 6.16 | 2.55 |
| Profit After Tax (PAT) | 1.32 | 4.33 | 1.36 |
| Net Worth | 12.04 | 10.72 | 6.39 |
| Total Assets | 31.83 | 28.12 | 20.26 |
| Reserves & Surplus | 5.77 | 4.45 | 5.61 |
| Borrowings | 7.83 | 7.26 | 6.82 |
| EBITDA Margin (%) | 24.60% | — | — |
| PAT Margin (%) | 17.27% | — | — |
Asston Pharmaceuticals Ltd. IPO is subscribed 1.00 times by Jul 11, 2025. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Asston Pharmaceuticals Ltd. IPO retail category is subscribed 1.00 times as of 11 Jul 2025. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 09 Jul 2025 and closes 11 Jul 2025. Min investment: ₹123,000 (1 lot = 1,000 shares). UPI mandate: 2025-07-11.
The Asston Pharmaceuticals Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website (Maashitla Securities Pvt.Ltd.) at https://maashitla.com/allotment-status/public-issues. Enter your PAN, application number or DP/Client ID. Allotment date: 14 Jul 2025. Refunds: on 15 Jul 2025.
The Asston Pharmaceuticals Ltd. IPO listing date is 16 Jul 2025, Wednesday. Listed on: BSE SME. Issue price: ₹123. Estimated listing: ₹123. GMP: NIL.
The Asston Pharmaceuticals Ltd. IPO closes on 11 Jul 2025, Friday. UPI mandate: 2025-07-11. Allotment: 14 Jul 2025. Listing: 16 Jul 2025.